2024
USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years
Siddique S, Wang R, Yasin F, Gaddy J, Zhang L, Gross C, Ma X. USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years. JAMA Network Open 2024, 7: e2436358. PMID: 39361285, PMCID: PMC11450516, DOI: 10.1001/jamanetworkopen.2024.36358.Peer-Reviewed Original ResearchConceptsUS Preventive Services Task ForceUS Preventive Services Task Force recommendationsColorectal cancer screening uptakeAverage-risk individualsScreening uptakeHigher socioeconomic statusSocioeconomic statusScreening recommendationsColorectal cancerColorectal cancer screening recommendationsPreventive Services Task ForceCohort studyCancer screening recommendationsScreening uptake ratesInterrupted time series analysisLow socioeconomic statusPrivate insurance beneficiariesScreening ratesSocioeconomic disparitiesRetrospective cohort studyMain OutcomesPotential disparitiesEvaluate changesClaims dataAbsolute change
2023
Using the Matrixed Multiple Case Study approach to identify factors affecting the uptake of IPV screening programs following the use of implementation facilitation
Adjognon O, Brady J, Iverson K, Stolzmann K, Dichter M, Lew R, Gerber M, Portnoy G, Iqbal S, Haskell S, Bruce L, Miller C. Using the Matrixed Multiple Case Study approach to identify factors affecting the uptake of IPV screening programs following the use of implementation facilitation. Implementation Science Communications 2023, 4: 145. PMID: 37990345, PMCID: PMC10664531, DOI: 10.1186/s43058-023-00528-x.Peer-Reviewed Original ResearchVeterans Health AdministrationImplementation facilitationUS Preventive Services Task ForceBackgroundIntimate partner violenceMethodsThis mixed-methods studyRoutine IPV screeningIntegrated Promoting ActionPrimary care clinicsHealth Services frameworkInternal facilitatorsVHA OfficeCare clinicsLarge trialsPrimary careMedical recordsPositive screenClinic staffPromoting ActionIPV screeningExternal facilitatorsWomen's healthHealth AdministrationSocial determinantsLarger studyHigh/medium
2022
Examining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening
Bold KW, Cannon S, Ford BB, Neveu S, Sather P, Toll BA, Fucito LM. Examining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening. Cancer Prevention Research 2022, 15: 327-333. PMID: 35063942, PMCID: PMC9064926, DOI: 10.1158/1940-6207.capr-21-0398.Peer-Reviewed Original ResearchConceptsLung cancer screeningCancer screeningTobacco treatmentWithdrawal symptomsRace/ethnicityTreatment perceptionsUS Preventive Services Task ForceHealth disparitiesAnnual lung cancerSmilow Cancer HospitalYale-New HavenCharacteristics of patientsHigh-risk patientsHigh-risk populationNon-Hispanic blacksTobacco-related health disparitiesAddress health disparitiesPatient characteristicsSmoking historyBlack patientsCancer HospitalLung cancerHigh riskPatientsSmokingChanges in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening
Leapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR, Gross CP, Ma X. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening. JAMA Oncology 2022, 8: 41-47. PMID: 34762100, PMCID: PMC8587214, DOI: 10.1001/jamaoncol.2021.5143.Peer-Reviewed Original ResearchConceptsProstate cancer screeningUS Preventive Services Task ForcePSA testingCancer screeningInterrupted time series analysisCohort studyUS Preventive Services Task Force (USPSTF) recommendationDraft statementLarge national cohort studyEligible beneficiariesPSA testing ratesRetrospective cohort studyRate of PSANational cohort studyProstate-specific antigenAge-adjusted ratesTask Force recommendationsUSPSTF guidelinesMedian ageGuideline changesProstate cancerMedian numberMAIN OUTCOMEClaims dataTesting rates
2021
Pelvic Examinations in the Adolescent and Young Adult Population: A Commentary on Why and When
Ahuja C, Cron J. Pelvic Examinations in the Adolescent and Young Adult Population: A Commentary on Why and When. Journal Of Pediatric And Adolescent Gynecology 2021, 34: 783-786. PMID: 34284079, DOI: 10.1016/j.jpag.2021.07.004.Peer-Reviewed Original ResearchConceptsUS Preventive Services Task ForcePatient-provider relationshipPelvic examinationAmerican CollegeInternal pelvic examinationYoung adult patientsYoung adult populationAsymptomatic patientsAdult patientsSpeculum examinationAsymptomatic adolescentsAdult populationAmerican AcademyPatientsStressful eventsExaminationAdolescentsTask ForcePractice utilityNonthreatening environmentGynecologistsObstetriciansPediatricsPhysiciansProfessional organizations
2020
Abrogation of survival disparity between Black and White individuals after the USPSTF′s 2012 prostate‐specific antigen–based prostate cancer screening recommendation
Kim I, Jang T, Kim S, Modi P, Singer E, Elsamra S, Kim I. Abrogation of survival disparity between Black and White individuals after the USPSTF′s 2012 prostate‐specific antigen–based prostate cancer screening recommendation. Cancer 2020, 126: 5114-5123. PMID: 32888321, DOI: 10.1002/cncr.33179.Peer-Reviewed Original ResearchConceptsUS Preventive Services Task ForceProstate cancerSurvival disparitiesWhite menProstate cancer screening recommendationsBlack menPCa-specific survivalAdverse clinical featuresCancer screening recommendationsEnd Results (SEER) databaseYear of diagnosisProstate-specific antigenClinical featuresScreening recommendationsResults databaseSurvival outcomesGrade CGrade D.White individualsMenRacial discrepanciesSurvivalTask ForceOutcomesTotal
2017
Aspirin for Primary Prevention
Richman IB, Owens DK. Aspirin for Primary Prevention. 2017, 101: 713-724. PMID: 28577622, DOI: 10.1016/j.mcna.2017.03.004.BooksMeSH KeywordsAge FactorsAspirinCardiovascular DiseasesColorectal NeoplasmsDiabetes MellitusGastrointestinal HemorrhageHumansHypertensionLipidsMyocardial InfarctionPlatelet Aggregation InhibitorsPractice Guidelines as TopicPrimary PreventionRacial GroupsRisk AssessmentRisk FactorsSex FactorsSmokingStrokeConceptsColorectal cancerPrimary preventionCardiovascular diseaseUS Preventive Services Task ForceNonfatal myocardial infarctionCardiovascular disease riskAdults age 50Intracranial bleedingOlder patientsMyocardial infarctionSelect populationAge 50AspirinAdults 60Disease riskAvailable evidenceRiskCancerDiseasePreventionTask ForceBleedingInfarctionPatientsStroke
2016
Lung cancer screening
Tanoue LT. Lung cancer screening. Current Opinion In Pulmonary Medicine 2016, 22: 327-335. PMID: 27159896, DOI: 10.1097/mcp.0000000000000287.Peer-Reviewed Original ResearchConceptsLung cancer screeningLow-dose chestCancer screeningUS Preventive Services Task ForceNational Lung Screening TrialFuture screening practicesLung cancer mortalityHigh-risk individualsIndividualized risk assessmentTobacco treatmentCancer mortalityFalse-positive resultsLung cancerPositive screenChest radiographyScreening practicesInvasive testingScreening TrialLung cancer biomarkersMultidisciplinary programHigh false positive ratePotential harmOngoing studiesChestRelative reductionPairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA, Committee F. Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016, 122: 1150-1159. PMID: 26916412, PMCID: PMC4828323, DOI: 10.1002/cncr.29926.Peer-Reviewed Original ResearchConceptsLung cancer screeningSmoking cessation interventionUS Preventive Services Task ForceLow-dose computed tomographyCancer screeningSmoking cessationTobacco useEvidence-based smoking cessation interventionsAge 55Evidence-based smoking cessation treatmentLung cancer screening participantsAnnual lung cancerPatients age 55Pack-year historySmoking cessation effortsSmoking cessation servicesSmoking cessation treatmentHigh-risk groupEvidence-based treatmentsEvidence-based behavioral strategiesScreening participantsLung cancerClinical guidelinesClinical recommendationsPremature mortality
2014
Screening for Nonviral Sexually Transmitted Infections in Adolescents and Young Adults
Murray P, Braverman P, Adelman W, Breuner C, Levine D, Marcell A, Murray P, O’Brien R, Burstein G. Screening for Nonviral Sexually Transmitted Infections in Adolescents and Young Adults. 2014, 134: e302-e311. PMID: 24982099, PMCID: PMC8194454, DOI: 10.1542/peds.2014-1024.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply